Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial

肥胖 医学 小檗碱 内科学 内分泌学 糖尿病 瘦素 脂肪组织 体质指数 超重 脂联素 胰岛素 疾病 体重 体力活动 2型糖尿病
作者
Lubi Lei,B. Wang,Lingshan Zhao,Jingkuo Li,Xiaofang Yan,Jiandong Jiang,Lulu Wang,Gang Ren,Yinchu Li,Xiaoguang Cheng,Xiaoyan Yan,Yidan Zhu,Guo Yuanlin,Hui Zhong,Haibo Zhang,Jing Li,BRAVO Collaborative Group,Xiaojian Liu,Yinming Bai,Hui Zheng
出处
期刊:JAMA network open [American Medical Association]
卷期号:9 (1): e2554152-e2554152 被引量:24
标识
DOI:10.1001/jamanetworkopen.2025.54152
摘要

Importance: Berberine is a potential therapy for metabolic disorders, yet its effects on visceral adipose tissue (VAT) and liver fat remain uncertain. Objectives: To evaluate the efficacy and safety of berberine in reducing VAT area and liver fat content in diabetes-free individuals with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Design, Setting, and Participants: In this multicenter, double-blind randomized clinical trial, diabetes-free individuals with obesity and MASLD were enrolled at 11 hospitals in China between July 6 and December 29, 2023, with a follow-up duration of 6 months. Interventions: Participants were randomly assigned to receive either oral berberine, 1 g/d, or a matching placebo. Main Outcomes and Measures: The primary outcomes were relative percentage change in VAT area and absolute change in liver fat content assessed by computed tomography. Other outcomes included changes in parameters of glucose, lipids, and inflammation. Analyses were conducted according to the intention-to-treat principle. Results: Among 337 randomized participants (mean [SD] age, 41.8 [10.6] years; 221 [65.6%] male), 169 received berberine and 168 placebo. The mean (SD) medication adherence rates were 90.3% (14.7%) for berberine and 90.7% (17.4%) for placebo. No significant differences were observed between study arms for VAT area (1.4% [97.5% CI, -2.4% to 5.2%]) or liver fat content (0.9% [97.5% CI, -0.4% to 2.1%). Berberine was associated with larger reductions in low-density lipoprotein cholesterol (-7.72 [95% CI, -13.13 to -1.93] mg/dL), apolipoprotein B (-3.42 [95% CI, -6.33 to -0.51] mg/dL) and high-sensitivity C-reactive protein (hs-CRP) (-0.072 [95% CI, -0.140 to -0.004] mg/dL) vs placebo, but not other secondary outcomes. The incidence of adverse events was similar between study arms. Post hoc analyses suggested consistent patterns of larger reductions in low-density lipoprotein cholesterol, apolipoprotein B, and hs-CRP levels in participants with higher baseline hs-CRP levels. Conclusions and Relevance: In this randomized clinical trial of diabetes-free individuals with obesity and MASLD, a 6-month berberine treatment at a daily dose of 1 g had an excellent safety profile but did not reduce VAT area or liver fat content. Trial Registration: ClinicalTrials.gov Identifier: NCT05647915.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jiangmax发布了新的文献求助10
刚刚
刚刚
小太阳发布了新的文献求助10
刚刚
1秒前
1秒前
刘淑蕊完成签到 ,获得积分10
1秒前
大时钟的应助被jinmei2025采纳,获得10
1秒前
null的应助被发SCI超人采纳,获得10
2秒前
我是老大的应助被畅快怜容采纳,获得10
2秒前
桐桐的应助被Yang123采纳,获得10
3秒前
慕辰发布了新的文献求助20
3秒前
不喝可乐汽水完成签到,获得积分10
3秒前
zzz发布了新的文献求助10
5秒前
5秒前
lan完成签到,获得积分10
5秒前
搜集达人的应助被小天采纳,获得10
6秒前
万能图书馆的应助被个性向卉采纳,获得10
7秒前
NN完成签到,获得积分10
8秒前
困困的关注了科研通微信公众号
9秒前
星辰大海的应助被调皮尔白采纳,获得10
10秒前
陈永伟完成签到,获得积分0
10秒前
Lucas的应助被Luna采纳,获得10
10秒前
科研通AI65的应助被XZ采纳,获得10
10秒前
10秒前
人间慈悲的应助被孟yifan采纳,获得10
11秒前
Jasper的应助被安宇采纳,获得10
11秒前
吃遍幼儿园完成签到 ,获得积分10
11秒前
12秒前
穆悦悦完成签到 ,获得积分10
13秒前
Yang123发布了新的文献求助10
14秒前
14秒前
jinmei2025完成签到,获得积分10
14秒前
木木木木木完成签到 ,获得积分10
15秒前
15秒前
15秒前
orixero的应助被LLvv采纳,获得10
15秒前
zxy完成签到,获得积分10
15秒前
四夕发布了新的文献求助10
17秒前
mm完成签到,获得积分10
18秒前
wky发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187210
求助须知:如何正确求助?哪些是违规求助? 9575379
关于积分的说明 21840916
捐赠科研通 7784939
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559340
邀请新用户注册赠送积分活动 2481793